Search Results - "Findlay, M P"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II by Harvey, V.J., Sharples, K.J., Isaacs, R.J., Jameson, M.B., Jeffery, G.M., McLaren, B.R., Pollard, S., Riley, G.A., Simpson, A.B., Hinder, V.A., Scott, J.N., Dzhelali, M.V., Findlay, M.P.

    Published in Annals of oncology (01-07-2013)
    “…Capecitabine and cyclophosphamide are active in patients with advanced breast cancer, have non-overlapping toxic effects and synergy pre-clinically. We…”
    Get full text
    Journal Article
  2. 2

    Chemotherapy-induced reversible posterior leucoencephalopathy syndrome by Han, C. H., Findlay, M. P.

    Published in Internal medicine journal (01-02-2010)
    “…Reversible posterior leucoencephalopathy syndrome is a neurological condition seen in various areas of acute medicine, including the administration of…”
    Get full text
    Journal Article
  3. 3

    Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy by FINDLAY, M. P. N, CUNNINGHAM, D, MORGAN, G, CLINTON, S, HARDCASTLE, A, AHERNE, G. W

    Published in British journal of cancer (1997)
    “…The increasing interest in 5-fluorouracil (5-FU) modulation and the development of new antifolates has focused attention in recent studies on the expression of…”
    Get full text
    Journal Article
  4. 4

    The Cost of Admiralty: The development and condition of Britain's modern naval shipbuilding programme, 1832-2015 by Findlay, M P

    Published in Journal of military and strategic studies (01-01-2015)
    “…Reform of government institutions is no new affair; indeed, government reform is like a chameleon that changes colours. Today's colour is military procurement…”
    Get full text
    Journal Article
  5. 5

    High CYP2C19 phenotypic variability in gastrointestinal cancer patients by Burns, K. E., Lo, W.-Y., Findlay, M. P., Sharples, K., Laking, G., Helsby, N. A.

    Published in Cancer chemotherapy and pharmacology (01-01-2016)
    “…Purpose CYP2C19 contributes to the metabolism of several chemotherapeutic agents. The CYP2C19 homozygous null function genotype strongly predicts activity…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study by Findlay, M P, Leach, M O, Cunningham, D, Collins, D J, Payne, G S, Glaholm, J, Mansi, J L, McCready, V R

    Published in Annals of oncology (01-08-1993)
    “…5-Fluorouracil (5-FU) is the most widely used cytotoxic drug in oncology and the only one useful in the management of colorectal cancer - a leading cause of…”
    Get more information
    Journal Article
  8. 8

    Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: Late relapse may occur by Boyer, Michael J., Cox, Keith, Tattersall, Martin H.N., Findlay, Michael P.N., Grygiel, John, Rogers, John

    Published in Urology (Ridgewood, N.J.) (01-10-1997)
    “…To review the outcome of men with Stage I nonseminomatous germ cell tumors managed with a policy of active surveillance following orchiectomy. The clinical…”
    Get full text
    Journal Article
  9. 9

    Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means? by Findlay, M P, Griffin, A M, Raghavan, D, McDonald, K E, Coates, A S, Duval, P J, Gianoutsos, P

    Published in European journal of cancer (1990) (1991)
    “…Between 1978 and 1983, 72 patients aged 70 years or older (median 72, range 70-80) were treated for biopsy-proven, small cell lung cancer (SCLC). Intercurrent…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    The case for a student honor code and beyond by Davis, Mardell, Johnston, Sarah R., DiMicco, Wendy, Findlay, Margaret P., Taylor, Judy A.

    Published in Journal of professional nursing (1996)
    “…Preparing graduates to enter practice as responsible and accountable nurses is an essential goal of nursing programs. Faculty must be deliberate in their…”
    Get full text
    Journal Article
  14. 14

    A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II by Harvey, V J, Sharples, K J, Isaacs, R J, Jameson, M B, Jeffery, G M, McLaren, B R, Pollard, S, Riley, G A, Simpson, A B, Hinder, V A, Scott, J N, Dzhelali, M V, Findlay, M P

    Published in Annals of oncology (01-07-2013)
    “…Capecitabine and cyclophosphamide are active in patients with advanced breast cancer, have non-overlapping toxic effects and synergy pre-clinically. We…”
    Get full text
    Journal Article
  15. 15
  16. 16

    In vivo monitoring of fluoropyrimidine metabolites: magnetic resonance spectroscopy in the evaluation of 5-fluorouracil by Findlay, M P, Leach, M O

    Published in Anti-cancer drugs (01-06-1994)
    “…Since 5-fluorouracil (5-FU) was synthesized in the late 1950s it has become an important component of many anticancer treatment regimens. The increasing volume…”
    Get more information
    Journal Article
  17. 17

    Rocuronium pretreatment reduces suxamethonium-induced myalgia: comparison with vecuronium by Findlay, G P, Spittal, M J

    Published in British Journal of Anaesthesia (01-04-1996)
    “…We have studied, in 150 patients undergoing elective oral surgery, the effectiveness and sequelae of pretreatment with rocuronium for reducing myalgia after…”
    Get full text
    Journal Article Conference Proceeding